Denise Damek, MD
Associate Professor, Neurology

Photo
Download CV
Medical School:
  • MD, University of Texas Medical School at Houston (1992)
Undergraduate School:
  • BS, University of Texas–Austin (TX) (1988)
Internship:
  • College of Medicine, Mayo Clinic (Rochester) Program (1993)
Residency:
  • College of Medicine, Mayo Clinic (Rochester) Program, Psychiatry (1996)
Fellowships:
  • Massachusetts General Hospital Program, Neuro-Oncology (1998)
Languages: English
Department: Neurology

Professional Titles

  • Associate Professor of Neurology

Publications

  • Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2019 Mar 1;84(3):687-695. PubMed PMID: 29618103
  • Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018 Jun;128(6):1713-1718. PubMed PMID: 28753117
  • Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2018 Mar 30. [Epub ahead of print] PubMed PMID: 29618103
  • Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma. CNS Oncol. 2017 Jan;6(1):29-43. PubMed PMID: 27628854
  • Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2017 Jul 28;:1-6. [Epub ahead of print] PubMed PMID: 28753117
  • Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma. CNS Oncol. 2016 Sep 15. [Epub ahead of print] PubMed PMID: 27628854
  • Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun;123(2):251-7. PubMed PMID: 25920710
  • Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar;122(1):135-43. PubMed PMID: 25524817
  • Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Barón AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):894-902. PubMed PMID: 25585784
  • Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2014 Dec 19. [Epub ahead of print] PubMed PMID: 25524817
  • Damek DM. Leptomeningeal enhancement in a 58-year-old woman. Oncology (Williston Park). 2014 May;28(5):438, 440. PubMed PMID: 25004660
  • Poonia S, Berge EM, Aisner DL, Damek D, Doebele RC. EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapy. Clin Lung Cancer. 2014 Sep;15(5):387-9. PubMed PMID: 24894944
  • Cloughesy TF, Petrecca K, Walbert T, Butowski N, Salacz M, Perry J, Damek D, Bota D, Bettegowda C, Zhu J-J, Iwamoto F, Placantonakis D, Kim L, Elder B, Kaptain G, Cachia D, Moshel Y, Brem S, Piccioni D, Landolfi J, Chen CC, Gruber H, Rao A, Hogan D, Accomando W, Ostertag D, Montellano TT, Kheoh T, Kabbinavar F, Vogelbaum MA. Vocimagene amiretrorepvec in combination with Toca FC in patients with recurrent high-grade glioma. Submitted to JAMA Oncology March 2020.
View All (13 Total) View Less

Professional Memberships

  • Society for Neuro-Oncology, Member
  • American Academy of Neurology, Member
  • American Medical Association, Member

Practice Locations

UCH - Cancer Center
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Court, Anschutz Cancer Pavilion, 2nd Floor, Suite 2004
Aurora, CO 80045
720-848-0300

Neurosciences Center - Anschutz
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Neurology, Board Certification (1998)
  • United Council for Neurologic Subspecialties, Specialized Training (2008)
Conditions & Treatments
  • Brain and Nervous System - Spine Diseases and Conditions
  • Cancers
  • Brain and Nervous System
  • Brain and Nervous System - Brain Tumors

General Information

Medical Schools:
  • MD, University of Texas Medical School at Houston (1992)
Undergraduate Schools:
  • BS, University of Texas–Austin (TX) (1988)
Internships:
  • College of Medicine, Mayo Clinic (Rochester) Program (1993)
Residency Programs:
  • College of Medicine, Mayo Clinic (Rochester) Program, Psychiatry (1996)
Fellowships:
  • Massachusetts General Hospital Program, Neuro-Oncology (1998)
Download CV
Languages: English
Department: Neurology
SOM Resources
CU Resources
Contact Us
(303) 724-0100
Building 500 N2229

Update My Profile
;